Group items tagged

Breast cancer survivors (BCS) exhibit decreased physical function and quality of life (QOL) following cancer treatments. Resistance training (RT) may elicit positive changes in physical and mental well-being. This study assessed 27 BCS, pre-and post-intervention (six months) on the following variables: muscular strength (via one repetition maximum (1RM) of chest press and leg extension), physical function (via the Continuous Scale-Physical Functional Performance test) and QOL (via the Short Form-36 survey). RT consisted of two days/week of ten exercises including two sets of 8-12 repetitions at 52%-69% of their 1RM. A repeated measures analysis of variance revealed BCS significantly (p < 0.05) increased upper (71 ± 22 to 89 ± 22 kg) and lower body (74 ± 18 to 93 ± 24 kg) strength, total physical function (65.5 ± 12.1 to 73.6 ± 12.2 units) and the subcomponents of physical function: upper body strength (63.5 ± 16.3 to 71.2 ± 16.8 units), lower body strength (58.5 ± 14.9 to 68.6 ± 16.3 units), balance and coordination (66.5 ± 12.2 to 74.6 ± 11.6 units), and endurance (67.2 ± 12.0 to 75.0 ± 11.6 units). No changes were observed over time for subjective measures of physical function and QOL. Results showed RT could be an effective means to improve objective physical function in BCS. Further research is needed to clarify the effects of RT on subjective physical function and QOL.

Overall QOL, but pain associated QOL was improved with metronomic very MTD.

Testosterone levels appear to be more of a biomarker of poor health in older men that are obese with diabetes.  More of these men had low free Testosterone (calc) versus Total Testosterone.  Using QOL questionnaires, weak correlation (not statistically significant) with androgen deficiency symptoms and ED were found.

Patients with liver cirrhosis will have low BCAA and thus supplementation proves to improve survival and QOL measures.

BCAA beneficial in malnutrition, anorexia, and QOL measures in patients with liver failure.

BCAA beneficial in hepatic encephalopathy, but no benefit in mortality, QOL measures, or nutritional parameters due to studies included.

Low Testosterone is common among male cancer survivors after therapy.  Many studies point to low T at the time of diagnosis as a prognostic biomarker.  The low T impairs QOL in this men.

Testosterone found to improve QOL measures in patients with cancer cachexia.

Mistletoe improves QOL in database review.

IV glutathione reduces the toxicity of cisplatin in women treated for ovarian cancer.  Quality of life also improved

IR sauna improves quality of life measures in patients with type II diabetes

watch out!  bioidentical progesterone provides improved symptom control versus synthetic progestin MPA

Small study in men s/p Testicular cancer found no association between Testosterone levels and quality of life measures.